Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.

The U.S. Environmental Protection Agency has drafted a plan to eliminate all limits on greenhouse gases from coal and ...

Zepbound injection is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in single-dose pen or single-dose vial. Zepbound is a prescription medicine. For more information ...

The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

Zepbound (tirzepatide ... The recommended starting dosage is 2.5 mg injected once per week for 4 weeks. This low dose helps your body get used to the medication. It also reduces your risk of ...

The company is adding 7.5mg and 10mg vials of Zepbound (tirzepatide) to its product range, adding to 2.4mg and 5mg vials launched last year, which are designed to make it easier for people paying ...

With political action underway through an executive order from President Donald Trump and pharmaceutical industry shifts emerging, the question remains whether these changes will lead to sustained ...

(Reuters) -After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs ...

Apnimed will be waiting for the readout from a second Phase III trial before it approaches the FDA with an NDA for the sleep ...

Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that it said would make it easier for people paying for the drug out-of-pocket to afford treatment.